Please login to the form below

Apadaz

This page shows the latest Apadaz news and features for those working in and with pharma, biotech and healthcare.

FDA panel backs Pfizer and Teva abuse-resistant painkillers

Last month the same panel also rejected an abuse-deterrent claim for KemPharm's Apadaz (benzhydrocodone hydrochloride and acetaminophen) whilst backing approval of the drug.

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Engagement Specialist, Healthcare Brand Communications, London, ...: circa £50K

PRINCIPAL MEDICAL WRITER > ETL - LONDON / NEW YORK/ HOME - ME...: Salary TBC

Home-based Senior Project Manager – Independent Med Ed: Salary TBC

Senior Account Manager: Competitive Salary Offered

Account Director, Healthcare Marketing Agency: Salary TBC

Account Director, Medical Education: Salary TBC

Account Director – Healthcare Marketing – Berks: Salary TBC

Senior Medical Writer: Salary TBC

Account Director: Competitive Salary Offered

Account Manager / Senior Account Manager: 35, 000-40, 000

Account Director – Health Policy – Global Agency: Salary TBC

Editorial Assistant Medical Education Agency: £25, 000 - £26, 000

Business Director: Competitive Salary Offered

Senior Account Director development role to Business Director, H...: Excellent package

Global Business Development Director – Health Education: excellent commission

Medical Writer: Salary TBC

Technical Manager – Developer and Commercial Excellence, Healthc...: Excellent package

Senior Account Manager, Rare Diseases – Medical Communications, ...: Excellent package

Account Manager / Account Director: Competative

Client Services Director – Medical Education Agency – North West...: Salary TBC

Engagement Expert, Healthcare Brand Communications, London: Excellent package

Associate Director: £75, 000-90, 000

Subscribe to our email news alerts

PMHub

Add my company

Accession

Accession was a born from a passion and a vision. A passion to harness the power of market access to...

Latest intelligence

China’s clinical trial shake-up: As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...
Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?: Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement: Pharma has agreed to capped growth again - in exchange for uptake promises...